Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a place.

Hospital staff should use more than one method to detect adverse events and potential adverse events: incident reporting, pharmacist surveillance and local real-time record review may all have a place.

BACKGROUND: Over the past five years, in most hospitals in England and Wales, incident reporting has become well established but it remains unclear how well reports match clinical adverse events. International epidemiological studies of adverse events are based on retrospective, multi-hospital case...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Olsen, S, Neale, G, Schwab, K, Psaila, B, Patel, T, Chapman, E, Vincent, C
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2007

Míreanna comhchosúla

The reasons of the nursing staff to notify adverse events
de réir: Miriam Cristina Marques da Silva de Paiva, et al.
Foilsithe / Cruthaithe: (2014-10-01)

Role of the Clinical Pharmacist in Reducing Preventable Adverse Drug Events
de réir: Bahir A.Mshiemish
Foilsithe / Cruthaithe: (2017-03-01)

Postmarketing Surveillance of Full Spectrum Hemp Extract CBD Products: Reported Adverse Events and Serious Adverse Events
de réir: Colleen M. Kingsbury, et al.
Foilsithe / Cruthaithe: (2024-09-01)

In light of recent events, we may have to see adverse effect profile in new perspective
de réir: Sahjid Mukhida, et al.
Foilsithe / Cruthaithe: (2024-11-01)

Internal Strengths for Adverse Life Events
de réir: Jian Zhao, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Exploring the causes of adverse events in NHS hospital practice.
de réir: Neale, G, et al.
Foilsithe / Cruthaithe: (2001)

Unveiling unexpected adverse events: post-marketing safety surveillance of gilteritinib and midostaurin from the FDA Adverse Event Reporting database
de réir: Tingting Jiang, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Preventing drug-related adverse events following hospital discharge: the role of the pharmacist
de réir: Nicholls J, et al.
Foilsithe / Cruthaithe: (2017-02-01)

Failure to obtain informed consent should also be considered an adverse event
de réir: Gabriel M. Fonseca, et al.
Foilsithe / Cruthaithe: (2020-06-01)

Adverse events in British hospitals: preliminary retrospective record review.
de réir: Vincent, C, et al.
Foilsithe / Cruthaithe: (2001)

Case record review of adverse events: a new approach.
de réir: Woloshynowych, M, et al.
Foilsithe / Cruthaithe: (2003)

Adverse event management
de réir: Aline Gonzalez Vigani

The Adverse Event Paradox
de réir: Thomas Milovac
Foilsithe / Cruthaithe: (2022-05-01)

Consumers’ adverse drug event reporting via community pharmacists: three stakeholder perception
de réir: Tanattha Kitisopee, et al.
Foilsithe / Cruthaithe: (2022-12-01)

Embedding surveillance into clinical care to detect serious adverse events in pregnancy
de réir: Seale, A, et al.
Foilsithe / Cruthaithe: (2015)

Surveillance on the adverse events following immunization with the pentavalent vaccine in Zhejiang, China
de réir: Xuejiao Pan, et al.
Foilsithe / Cruthaithe: (2022-01-01)

PrePex circumcision surveillance: Adverse events and analgesia for device removal.
de réir: Limakatso Lebina, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Adverse Events of Antiepileptic Drugs Using Indonesian Version of Liverpool Adverse Events Profile
de réir: Astri Budikayanti, et al.
Foilsithe / Cruthaithe: (2018-01-01)

Indications and adverse events of teriparatide: based on FDA adverse event reporting system (FAERS)
de réir: Ming-Tao Wen, et al.
Foilsithe / Cruthaithe: (2024-08-01)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
de réir: Bin Zhao, et al.
Foilsithe / Cruthaithe: (2018-10-01)

AE-GPT: Using Large Language Models to extract adverse events from surveillance reports-A use case with influenza vaccine adverse events.
de réir: Yiming Li, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Adverse events following immunization among the elderly having booster COVID-19 vaccine: an active surveillance in Guiyang city
de réir: Na YU, et al.
Foilsithe / Cruthaithe: (2022-09-01)

Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic
de réir: Donaldson M, et al.
Foilsithe / Cruthaithe: (2013-06-01)

Understanding and responding to adverse events.
de réir: Vincent, C
Foilsithe / Cruthaithe: (2003)

Minor Adverse Events Postcolonoscopy
de réir: Catherine Dubé
Foilsithe / Cruthaithe: (2014-01-01)

Evaluating adverse events in databases
de réir: Katie Lovell, et al.
Foilsithe / Cruthaithe: (2023-10-01)

Adverse Events of DOACs in Children
de réir: Alessandra Bosch, et al.
Foilsithe / Cruthaithe: (2022-07-01)

Analysis of postmarketing neuropsychiatric adverse events of avapritinib based on the FDA adverse event reporting system
de réir: Wei Mao, et al.
Foilsithe / Cruthaithe: (2025-01-01)

Analysis of post-market adverse events of tafamidis base on the FDA adverse event reporting system
de réir: Fan Wu, et al.
Foilsithe / Cruthaithe: (2024-06-01)

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
de réir: Kaito Yamashiro, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Adverse Events Related to Off-Label Drugs Using Spontaneous Adverse Event Reporting Systems
de réir: Han N, et al.
Foilsithe / Cruthaithe: (2021-08-01)

Assessing taxane-associated adverse events using the FDA adverse event reporting system database
de réir: Dong-Hui Lao, et al.
Foilsithe / Cruthaithe: (2021-06-01)

Surveillance for adverse events following immunization in Hebei Province, China, 2018-2020
de réir: Li Sun, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Reinforcing Surveillance for Vaccine-Associated Adverse Events: The Advisory Committee on Causality Assessment
de réir: Robert Pless, et al.
Foilsithe / Cruthaithe: (1996-01-01)

Surveillance on the adverse events following immunization in Dazu District of Chongqing， 2016‒2020
de réir: WANG Qian, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events
de réir: Yunha Noh, et al.
Foilsithe / Cruthaithe: (2023-06-01)

Public Health Surveillance for Adverse Events Following COVID-19 Vaccination in Africa
de réir: AbdulAzeez Adeyemi Anjorin, et al.
Foilsithe / Cruthaithe: (2022-04-01)

Active surveillance study of adverse events following immunisation of children in the Czech Republic
de réir: Jana Danova, et al.
Foilsithe / Cruthaithe: (2017-02-01)

Adverse event versus medication error: perceptions of nursing staff acting in intensive care
de réir: Patrícia Cabral Ferreira, et al.
Foilsithe / Cruthaithe: (2014-03-01)

Adverse event versus medication error: perceptions of nursing staff acting in intensive care
de réir: Patrícia Cabral Ferreira, et al.
Foilsithe / Cruthaithe: (2014-03-01)